267 related articles for article (PubMed ID: 27805524)
1. De Novo Malignant Neoplasms in Renal Transplant Patients.
Yılmaz Akçay E; Tepeoğlu M; Özdemir BH; Deniz E; Börcek P; Haberal M
Exp Clin Transplant; 2016 Nov; 14(Suppl 3):100-105. PubMed ID: 27805524
[TBL] [Abstract][Full Text] [Related]
2. Postrenal transplant malignancy: Incidence, risk factors, and prognosis.
Elserwy NA; Lotfy EE; Fouda MA; Mahmoud MI; Donia AF; Mashaly ME; Abbas MH; Abuelmagd MM; Abouelenein RK; Ismail MI; Bakr MA
Saudi J Kidney Dis Transpl; 2017; 28(3):579-588. PubMed ID: 28540896
[TBL] [Abstract][Full Text] [Related]
3. Association of Pretransplant Skin Cancer With Posttransplant Malignancy, Graft Failure and Death in Kidney Transplant Recipients.
Kang W; Sampaio MS; Huang E; Bunnapradist S
Transplantation; 2017 Jun; 101(6):1303-1309. PubMed ID: 27336396
[TBL] [Abstract][Full Text] [Related]
4. Posttransplant Lymphoproliferative Disorders in Irish Renal Transplant Recipients: Insights From a National Observational Study.
OʼRegan JA; Prendeville S; McCaughan JA; Traynor C; OʼBrien FJ; Ward FL; OʼDonovan D; Kennedy C; Berzan E; Kinsella S; Williams Y; OʼKelly P; Deady S; Comber H; Leader M; Conlon PJ
Transplantation; 2017 Mar; 101(3):657-663. PubMed ID: 27214265
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Survival of Cancer After Pancreas-Kidney Transplantation.
Pendón-Ruiz de Mier MV; Agüera ML; Navarro MD; Rodriguez-Benot A; Aljama P
Transplant Proc; 2018 Mar; 50(2):669-672. PubMed ID: 29579884
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Outcomes of Renal Transplant in Patients With End-Stage Renal Failure Due to Systemic Lupus Erythematosus and Granulomatosis With Polyangiitis.
Considine SW; Davis NF; McLoughlin LC; Mohan P; Forde JC; Power R; Smyth G; Little DM
Exp Clin Transplant; 2019 Dec; 17(6):720-726. PubMed ID: 31580235
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and outcomes of renal transplantation in elderly recipients.
Nanmoku K; Matsuda Y; Yamamoto T; Tsujita M; Hiramitsu T; Goto N; Katayama A; Watarai Y; Kobayashi T; Uchida K
Transplant Proc; 2012 Jan; 44(1):281-3. PubMed ID: 22310633
[TBL] [Abstract][Full Text] [Related]
8. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
[TBL] [Abstract][Full Text] [Related]
9. Posttransplant Malignancies in Adult Renal and Hepatic Transplant Patients.
Rahatli S; Altundag O; Ayvazoglu Soy E; Moray G; Haberal M
Exp Clin Transplant; 2020 Aug; 18(4):470-473. PubMed ID: 30119617
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma of the native kidney: a frequent tumor after kidney transplantation with favorable prognosis in case of early diagnosis.
Végsö G; Toronyi E; Hajdu M; Piros L; Görög D; Deák PA; Doros A; Péter A; Langer RM
Transplant Proc; 2011 May; 43(4):1261-3. PubMed ID: 21620106
[TBL] [Abstract][Full Text] [Related]
11. The effect of pretransplant chronic hepatitis C virus infection treatment on graft and patient survival in renal transplant recipients.
Korkmaz M; Fakı S; Öcal S; Harmancı Ö; Ensaroğlu F; Selçuk H; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():188-92. PubMed ID: 25894152
[TBL] [Abstract][Full Text] [Related]
12. Frequency of the Original Kidney Disease and Its Effect on the Outcome of Kidney Transplant in the Urology-Nephrology Center Mansoura University.
Mashaly ME; Ismail MI; Lotfy EE; Donia AF; Wafa IW; Foda MA; Denewar AA; Abbas MH; Shokeir AA
Exp Clin Transplant; 2016 Apr; 14(2):157-65. PubMed ID: 26788876
[TBL] [Abstract][Full Text] [Related]
13. De Novo Visceral Malignancies in Renal Transplant Recipients: A Single Center Experience of 2054 Recipients for More Than 30 Years.
Zavos G; Moris D; Kostakis ID; Vernadakis S; Bokos J; Zavvos V; Lionaki S; Boletis J
Exp Clin Transplant; 2015 Aug; 13(4):313-8. PubMed ID: 26295181
[TBL] [Abstract][Full Text] [Related]
14. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
[TBL] [Abstract][Full Text] [Related]
15. Nonmelanoma Skin Cancers in Solid-Organ Transplant Recipients: A Single Center Experience.
Albayati A; Ozkan B; Eyuboglu AA; Uysal AC; Markal Ertas N; Haberal M
Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):95-100. PubMed ID: 29528001
[TBL] [Abstract][Full Text] [Related]
16. Proteinuria among renal transplant patients and its relation to hepatitis C virus and graft outcome: a single center experience.
Sabry A
Exp Clin Transplant; 2010 Jun; 8(2):91-7. PubMed ID: 20565364
[TBL] [Abstract][Full Text] [Related]
17. High Posttransplant Cancer Incidence in Renal Transplanted Patients With Pretransplant Cancer.
Hellström V; Lorant T; Döhler B; Tufveson G; Enblad G
Transplantation; 2017 Jun; 101(6):1295-1302. PubMed ID: 27163539
[TBL] [Abstract][Full Text] [Related]
18. Kidney transplantation in the US: an analysis of the OPTN/UNOS registry.
Freitas MC
Clin Transpl; 2011; ():1-16. PubMed ID: 22755397
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of growth in low-body-weight kidney transplant Egyptian children: 25-year experience.
Mosaad AM; Hamdy AF; Hassan NM; Donia AF; Gheith O; Salem Mel-S; El-Shahawy el-ML; Bakr MA; Ghoneim MA
J Nephrol; 2012; 25(3):363-72. PubMed ID: 22081295
[TBL] [Abstract][Full Text] [Related]
20. CD20 antigen expression by lymphoproliferative disorders after kidney transplant is independently associated with a poor outcome: PTLD.Int survey.
Khedmat H; Taheri S
Exp Clin Transplant; 2012 Aug; 10(4):325-31. PubMed ID: 22758374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
